AVAILABLE ON DEMAND

As new diseases emerge and existing diseases mutate, producers are facing complex decisions regarding how to make the best decisions for the health of their herds. Recent advances in vaccines offer new opportunities to combat many of the diseases that have been affecting livestock producers. The USDA Center for Veterinary Biologics (CVB) has released guidance allowing for the development and licensure of Prescription Platform Vaccines (RxPP). RxPP vaccines are a new category of vaccine that fills a gap that is not served by other vaccine types. RxPP vaccines are designed to address emerging and rapidly mutating diseases.

Joining us as speakers will be:

Mike Roof, PhD
Chief Technology Officer
State of Iowa Bioscience Initiative

Mike has over 25 years of experience in the Animal Health Industry and currently serves at the Chief Technology Officer for the State of Iowa Bioscience initiative. He has contributed to USDA and globally licensed vaccines as well as the USDA approval of Production Platform and Prescription Platform vaccines.

Mark Luecke
CEO
Medgene Labs

Mark Luecke is Co-Founder and CEO of Medgene Labs, an Immunological Services ProviderTM for leading livestock producers and their veterinarians. Raised on a small farm in South Dakota, Mark has served in executive leadership roles in large and small technology-based companies, as well as venture capital, private equity, and investment banking.

Dr. Alan Young
Chief Technology Officer
Medgene Labs

In 2011, Dr. Young founded Medgene Labs to assist in the translation of early-stage immunological technologies to the marketplace and to develop new vaccine and diagnostic tools for veterinary medicine. Through his work with Medgene Labs, he has focused on the application of rapid vaccine responses as newly regulated through the Prescription Vaccine pathway.

Andy Vance - Moderator
Director, Strategic Accounts
Farm Progress

SPONSORED BY